Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Lu-Ming Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110232730. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. Serum level of CCL2 predicts outcome of patients with pancreatic cancer. Last author PMID 32603049↗
  2. High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFP… Last author DOI 10.3892/ol.2014.2134↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 2 shared papers, 2014–2020 · strength 0.17
  2. P Wang · 1 shared paper, 2020 · strength 0.13
  3. Lanyun Feng · 1 shared paper, 2020 · strength 0.13
  4. Zhiqiang Meng · 1 shared paper, 2020 · strength 0.13
  5. Qi Qi · 1 shared paper, 2020 · strength 0.13
  6. Yongqiang Hua · 1 shared paper, 2014 · strength 0.04
  7. Yehua Shen · 1 shared paper, 2014 · strength 0.04
  8. Hao Chen · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.